Vieujean, S.; Caron, B.; Haghnejad, V.; Jouzeau, J.-Y.; Netter, P.; Heba, A.-C.; Ndiaye, N.C.; Moulin, D.; Barreto, G.; Danese, S.;
et al. Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. Int. J. Mol. Sci. 2022, 23, 7611.
https://doi.org/10.3390/ijms23147611
AMA Style
Vieujean S, Caron B, Haghnejad V, Jouzeau J-Y, Netter P, Heba A-C, Ndiaye NC, Moulin D, Barreto G, Danese S,
et al. Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. International Journal of Molecular Sciences. 2022; 23(14):7611.
https://doi.org/10.3390/ijms23147611
Chicago/Turabian Style
Vieujean, Sophie, Bénédicte Caron, Vincent Haghnejad, Jean-Yves Jouzeau, Patrick Netter, Anne-Charlotte Heba, Ndeye Coumba Ndiaye, David Moulin, Guillermo Barreto, Silvio Danese,
and et al. 2022. "Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models" International Journal of Molecular Sciences 23, no. 14: 7611.
https://doi.org/10.3390/ijms23147611
APA Style
Vieujean, S., Caron, B., Haghnejad, V., Jouzeau, J.-Y., Netter, P., Heba, A.-C., Ndiaye, N. C., Moulin, D., Barreto, G., Danese, S., & Peyrin-Biroulet, L.
(2022). Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. International Journal of Molecular Sciences, 23(14), 7611.
https://doi.org/10.3390/ijms23147611
